Telehealth pharmacist-led opioid education for cancer patients
Official title: Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study
Run by Fred Hutchinson Cancer Center · NCT07737314 · Data updated 2026-11-12
This pilot tests a telehealth group education session led by a palliative care pharmacist to help adults with cancer use opioids more safely and effectively.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Fred Hutchinson Cancer Center Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | November 3, 2026 |
| Main results expected | July 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07737314 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with cancer, established in Fred Hutch palliative care, currently prescribed opioids and able to participate in a telehealth session.
✕Probably not a fit
Patients not using opioids or those unable to participate in telehealth may not benefit from this education session.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional pilot study will assess the feasibility, acceptability, and potential efficacy of a pharmacist-led telehealth group education session on opioid use for cancer-related pain in palliative care patients. Participants with cancer who are prescribed opioids will complete surveys before, after, and within one month of the session, and a patient handout will summarize the education. Interventions include survey administration and review of electronic health records to capture outcomes. The study aims to identify barriers to safe opioid use and to inform future larger trials in this population.
Why it matters
Potential benefit: If successful, patients may achieve better symptom control with safer and more effective opioid use.
How similar studies have gone: Prior palliative care education initiatives via telehealth have shown improvements in knowledge and satisfaction among participants.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years, consistent with the population of patients treated at Fred Hutch Cancer Center * A cancer diagnosis * Established care in the Fred Hutch Palliative Care Clinic (≥ 1 visit with a Fred Hutch palliative care physician or advanced practice provider within the past 12 months) * Prescribed opioids, defined as either ≥ 1 opioid prescription within the past 6 months documented in the Washington Prescription Drug Monitoring Program (PDMP), or a new opioid prescription initiated by the referring palliative care provider at the time of referral * Ability to understand and willingness to agree to an electronic consent document * Enrolled in MyChart and ability to participate in a telehealth video visit Exclusion Criteria: * Patients who prefer a language other than English for healthcare, as the session will be conducted live and cannot currently be offered in other languages
Where it's running
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Nicole Dussault, MD, MS — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Sheri Ballard
- Email: sballard@fredhutch.org
- Phone: 206-667-4222
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if virtual informed consent methods help people decide to join cancer research
This trial tests whether virtual human communicators and different consent messages can influence cancer patients’ understanding and willingness to participate in research.
-
AI-powered supportive care chatbot for young adult cancer survivors
A chatbot driven by artificial intelligence is tested to help young adult cancer survivors manage symptoms and care needs after treatment.
-
Mindfulness program to help with symptoms in chronic graft-versus-host disease
A mindfulness-based program is being tested to see if it can reduce patient-reported symptoms for adults with chronic graft-versus-host disease after a stem cell transplant.
-
Non-invasive brain stimulation to help chemotherapy-induced nerve problems in cancer survivors
This trial tests whether a gentle brain stimulation method (tDCS) can help reduce numbness, tingling, and pain from CIPN in cancer survivors who are not currently in treatment.
-
Ambient sensor rooms to spot early problems in hospitalized cancer patients
This test will try whether special hospital rooms with cameras, microphones, and temperature sensors can help staff spot early delirium, falls, sleep problems, or mood changes in adults hospitalized with cancer.
-
Voices: sharing messages of wisdom and hope during illness
This project will see if recording semi-structured interviews with adult cancer patients (and optional caregivers) affects patients' sense of dignity and caregiver support.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.